Renalytix

Historical price data

Renalytix plc is a global diagnostics company with a mission to improve kidney health through AI-enabled risk prediction. Its key achievement is the FDA authorization and subsequent Medicare coverage determination for its KidneyIntelX.dkd prognostic test for diabetic kidney disease. The company's strategy is to commercialize this test and expand its platform to other kidney conditions, leveraging partnerships to drive adoption and integrate its solutions into standard care pathways.

An AI-enabled, multi-omics platform that integrates electronic health records, lab results, protein biomarkers, and genetic data to generate Bioprognostic™ risk scores for kidney disease progression.